12 Stocks Under $5 With Biggest Upside Potential

Page 10 of 11

2. OPKO Health, Inc. (NASDAQ:OPK)

Upside Potential: 169.39%

Stock Price as of January 17: $1.47

Number of Hedge Fund Investors: 22

OPKO Health, Inc. (NASDAQ:OPK) is a diversified healthcare company engaged in the development and commercialization of diagnostics, pharmaceuticals, and healthcare services. The company focuses on areas such as cancer, metabolic disorders, infectious diseases, and women’s health. OPKO Health, Inc. (NASDAQ:OPK) markets products such as Rayaldee, which is used to treat secondary hyperparathyroidism in adults with chronic kidney disease, and Somatrogon (marketed as NGENLA), a human growth hormone injection developed in partnership with Pfizer.

OPKO Health, Inc. (NASDAQ:OPK) is making progress with its oxyntomodulin analog, OPK-88006, which has shown promise in preclinical studies as a potential once-weekly injectable treatment for patients with obesity or metabolic disorders. The company is also collaborating with Entera Bio to develop an oral version of OPK-88006, which could offer a competitive edge in the marketplace.

Additionally, OPKO Health, Inc. (NASDAQ:OPK) is actively exploring partnerships and business development opportunities to foster growth and create value across its divisions. The company has also partnered with Merck to develop an Epstein-Barr virus multivalent nanoparticle vaccine, which is anticipated to enter clinical trials in the coming months.

Page 10 of 11